In today’s recent session, 1.52 million shares of the Biogen Inc (NASDAQ:BIIB) have been traded, and its beta is 0.15. Most recently the company’s share price was $127.42, and it changed around $0.86 or 0.68% from the last close, which brings the market valuation of the company to $18.67B. BIIB at last check was trading at a discount to its 52-week high of $238.00, offering almost -86.78% off that amount. The share price’s 52-week low was $110.04, which indicates that the recent value has risen by an impressive 13.64% since then. We note from Biogen Inc’s average daily trading volume that its 10-day average is 1.19 million shares, with the 3-month average coming to 1.67 million.
Biogen Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.08. If we narrow it down even further, the data shows that 0 out of 37 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 19 recommended BIIB as a Hold, whereas 13 deemed it a Buy, and 0 rated it as Underweight.
Biogen Inc (NASDAQ:BIIB) trade information
Instantly BIIB has been showing a green trend so far today with a performance of 0.68% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 134.12 on recent trading dayincreased the stock’s daily price by 5.0%. The company’s shares are currently down -16.68% year-to-date, but still down -4.24% over the last five days. On the other hand, Biogen Inc (NASDAQ:BIIB) is -1.56% down in the 30-day period. We can see from the shorts that 3.8 million shares have been sold at a short interest cover period of 2.15 day(s).
The consensus price target as assigned by Wall Street analysts is $187, which translates to bulls needing to increase their stock price by 31.86% from its current value. Analyst projections state that BIIB is forecast to be at a low of $118 and a high of $270.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -18.66%. Biogen Inc earnings are expected to increase by -9.99% in 2025, but the outlook is negative -0.76% per year for the next five years.
BIIB Dividends
Biogen Inc’s next quarterly earnings report is expected to be released on 2025-May-01.
Biogen Inc (NASDAQ:BIIB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.22% of Biogen Inc shares, and 92.92% of them are in the hands of institutional investors. The stock currently has a share float of 93.12%. Biogen Inc stock is held by 1314.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 11.4012% of the shares, which is about 16.6 million shares worth $3.85 billion.
PRIMECAP MANAGEMENT CO/CA/, with 11.2214% or 16.34 million shares worth $3.79 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
